<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03912662</url>
  </required_header>
  <id_info>
    <org_study_id>MDT17048POETRY</org_study_id>
    <nct_id>NCT03912662</nct_id>
  </id_info>
  <brief_title>ProGripTM Self-Gripping Polyester Mesh in Incisional Hernia Prevention</brief_title>
  <acronym>POETRY</acronym>
  <official_title>Poetry Study - ProGrip™ Self-gripping Polyester Mesh Prospective Embedded REgisTRY for Abdominal Wall Sutureline Reinforcement in Subjects Undergoing Midline Laparotomy to Prevent Incisional Hernia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic - MITG</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional, prospective, multicenter, post-marketing clinical follow-up study.&#xD;
&#xD;
      After midline laparotomy, the probability to develop an incisional hernia ranges from 10% to&#xD;
      50% depending on the complexity of the surgery and patient state of health.&#xD;
&#xD;
      As the clinical data needed for the study corresponds with those collected by Club Hernie&#xD;
      registry, the clinical study will use the established registry database to collect&#xD;
      performance and safety data on the prevention of incisional hernias within 24 months post&#xD;
      operatively.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 18, 2019</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incisional hernia rate</measure>
    <time_frame>24 months</time_frame>
    <description>Occurence of incisional hernia assessed by clinical examination and abdominal CT scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse event</measure>
    <time_frame>From the surgery to the 24-month visit</time_frame>
    <description>Adverse event incidence reported by number, severity, and relationship to the procedure and device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to incisional hernia occurrence</measure>
    <time_frame>From the surgery to the 24-month visit</time_frame>
    <description>Time to incisional hernia occurrence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain at the site of surgery with Visual Analog Scale (VAS)</measure>
    <time_frame>Day 0, Day 1, Day 8, Month 1, Month 12, Month 24</time_frame>
    <description>Assessment of post-operative pain using a 0 to 10 Visual Analogic Scale. Worst pain experienced over the last 24 hours.&#xD;
Mild pain for VAS score between 0 and 3. Moderate pain for VAS score &gt;3 and ≤6. Severe pain for VAS score &gt;6.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life questionnaire (QOL) for patient</measure>
    <time_frame>Month 12, Month 24</time_frame>
    <description>Assessment with Club Hernie registry QOL questionnaire of patient treated for suture line mesh reinforcement for long follow-up. Two sets of self-administered QOL and patient satisfaction questionnaire will be administered by phone call at 12 and 24 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life questionnaire (QOL) for patient</measure>
    <time_frame>Month 1</time_frame>
    <description>Assessment with Club Hernie registry QOL questionnaire of patient treated for suture line mesh reinforcement for long follow-up. A self-administered QOL questionnaire will be administered at 1 month.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgeon satisfaction</measure>
    <time_frame>Day 0</time_frame>
    <description>Surgeon satisfaction on mesh ease of use and manipulability will be collected in the Club Hernie registry database.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Incisional Hernia</condition>
  <arm_group>
    <arm_group_label>Hernia prevention cohort</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mesh augmented reinforcement</intervention_name>
    <description>Abdominal wall sutureline reinforcement with ProgripTM Self-Gripping Polyester Mesh</description>
    <arm_group_label>Hernia prevention cohort</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject has provided informed consent.&#xD;
&#xD;
          2. Subject is ≥ 18 years of age at the time of consent.&#xD;
&#xD;
          3. Subject will be undergoing an elective midline laparotomy.&#xD;
&#xD;
          4. Subject may have a combination of low- and high-risk factors but cannot exceed a total&#xD;
             of 5 risk factors or have more than 2 high-risk factors. Subject must have at least 2&#xD;
             low-risk factors if subject does not have any high-risk factors. High- and low-risk&#xD;
             factors include:&#xD;
&#xD;
               1. High-Risk Factors (maximum of 2): i.BMI≥ 35; ii.Prior open abdominal surgery;&#xD;
                  iii.Daily active smoker or Chronic Obstructive Pulmonary disease (COPD)&#xD;
                  diagnosis; iv. Current or recent (within 1 year) cancer diagnosis or chemotherapy&#xD;
                  treatment; v.History of or current abdominal aorta aneurism or surgery for&#xD;
                  abdominal aortaaneurism&#xD;
&#xD;
               2. Low-Risk Factors (minimum of 2, if no high-risk factors): i.25 ≤ BMI &lt; 35; ii.Age&#xD;
                  &gt; 45; iii.Uncontrolled diabetes; iv.Malnutrition as defined by 10% weight loss&#xD;
                  within the last 3 months; v.Current immunosuppressive treatment; vi.Undergoing&#xD;
                  colorectal surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subject is undergoing emergency surgery, i.e. lifesaving procedures performed where&#xD;
             subject is in imminent danger of death.&#xD;
&#xD;
          2. Subject for which the device is used outside the product IFU, including;&#xD;
&#xD;
               1. Pregnant women: Women who are known or suspected to be pregnant, or who are&#xD;
                  planning to become pregnant during the study follow-up period&#xD;
&#xD;
               2. Subject who has an infection within 30 days of enrollment or, at the time of the&#xD;
                  surgery, has any active, acute or chronic infection(s) that are uncontrolled&#xD;
                  and/or requiring treatment such as antibiotics&#xD;
&#xD;
               3. Subject whose surgical site is contaminated or dirty/infected intraoperatively,&#xD;
                  as assessed by the Investigator (Exclude Altemeier classification III-IV).&#xD;
&#xD;
          3. Subject who had received a mesh in a previous ventral hernia repair or has a ventral&#xD;
             hernia.&#xD;
&#xD;
          4. Investigator determined that a planned future surgery would interfere with application&#xD;
             of mesh reinforcement.&#xD;
&#xD;
          5. Subject has participated in an investigational drug or device research study within 30&#xD;
             days of enrollment.&#xD;
&#xD;
          6. Subject has a life expectancy of &lt;2 years.&#xD;
&#xD;
          7. Subject has an ASA Physical Status Classification System score &gt;3.&#xD;
&#xD;
          8. Subject has &gt;5 total risk factors or &gt;2 high-risk factors&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel Prudhomme, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nīmes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Federica Fonti</last_name>
    <phone>+39 3400637665</phone>
    <email>federica.fonti@medtronic.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Besançon</name>
      <address>
        <city>Besançon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Bordeaux - Hôpital Haut-Lévêque</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Lille</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>HCL Louis Pradel</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Nîmes</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Lyon Sud</name>
      <address>
        <city>Pierre-Bénite</city>
        <zip>69310</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes - Hôpital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Hopitaux de Rouen</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg - Nouvel Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Valenciennes</name>
      <address>
        <city>Valenciennes</city>
        <zip>59322</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 21, 2019</study_first_submitted>
  <study_first_submitted_qc>April 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 11, 2019</study_first_posted>
  <last_update_submitted>October 8, 2021</last_update_submitted>
  <last_update_submitted_qc>October 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Incisional Hernia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

